Gringeri A, Leissinger C, Cortesi PA, Jo H, Fusco F, Riva S, Antmen B, Berntorp E, Biasoli C, Carpenter S, Kavakli K, Morfini M, Négrier C, Rocino A, Schramm W, Windyga J, Zülfikar B, Mantovani LG. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study. Haemophilia. 2013 Sep
Chambost H, Santagostino E, Laffan M, Kavakli K; Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry. ONE Registry Steering Committee on behalf of the investigators. Haemophilia. 2013 Jul
Tiede A, Brand B, Fischer R, Kavakli K, Lentz SR, Matsushita T, Rea C, Knobe K, Viuff D. J Enhancing the pharmacokinetic properties of recombinant factor VIII: firstin- human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A. Thromb Haemost. 2013 Apr
Astermark J, Donfield SM, Gomperts ED, Schwarz J, Menius ED, Pavlova A, Oldenburg J, Kessing B, DiMichele DM, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. Blood. 2013 Feb 21
Powell J, Martinowitz U, Windyga J, Di Minno G, Hellmann A, Pabinger I, Maas Enriquez M, Schwartz L, Ingerslev J; LipLong Study Investigators. Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study. Thromb Haemost. 2012 Nov
Schwarz J, Astermark J, Menius ED, Carrington M, Donfield SM, Gomperts ED, Nelson GW, Oldenburg J, Pavlova A, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study Combined Cohort. F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. Haemophilia. 2013 Jan
Abshire TC, Federici AB, Alvárez MT, Bowen J, Carcao MD, Cox Gill J, Key NS, Kouides PA, Kurnik K, Lail AE, Leebeek FW, Makris M, Mannucci PM, Winikoff R, Berntorp E; VWD PN. Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN). Haemophilia. 2013 Jan
Ay Y, Balkan C, Karapinar DY, Akin M, Bilenoğlu B, Kavakli K. Feasibility of using thrombin generation assay (TGA) for monitoring of haemostasis during supplementation therapy in haemophilic patients without inhibitors. Haemophilia. 2012 Nov
Schramm W, Gringeri A, Ljung R, Berger K, Crispin A, Bullinger M, Giangrande PL, Von Mackensen S, Mantovani LG, Nemes L, Serban M; ESCHQOL Study Group. Haemophilia care in Europe: the ESCHQoL study. Haemophilia. 2012 Sep
Buyukinan M, Yilmaz D, Yalaz M, Koroglu OA, Akisu M, Kavakli K, Kultursay N. Long-term ongoing coagulopathy in premature infants with respiratory distress syndrome. Clin Appl Thromb Hemost. 2013 Sep
Berber E, Pehlevan F, Akin M, Capan OY, Kavakli K, Çaglayan SH. A common VWF exon 28 haplotype in the Turkish population. Clin Appl Thromb Hemost. 2013 Sep
de Paula EV, Kavakli K, Mahlangu J, Ayob Y, Lentz SR, Morfini M, Nemes L, Šalek SZ, Shima M, Windyga J, Ehrenforth S, Chuansumrit A; 1804 (adept(TM)1) Investigators. Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial. J Thromb Haemost. 2012 Jan
Ay Y, Balkan C, Karapinar DY, Akin M, Bilenoglu B, Kavakli K. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors. Clin Appl Thromb Hemost. 2013 Jul-Aug
Zülfikar B, Aydogan G, Salcioglu Z, Oner AF, Kavakli K, Gursel T, Zülfikar H; FEIBA Investigators Team. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey. Haemophilia. 2012 May
Akin M, Kavakli K. Laboratory diagnosis and management of von Willebrand disease in Turkey: Izmir experience. Semin Thromb Hemost. 2011 Jul
Leissinger C, Gringeri A, Antmen B, Berntorp E, Biasoli C, Carpenter S, Cortesi P, Jo H, Kavakli K, Lassila R, Morfini M, Négrier C, Rocino A, Schramm W, Serban M, Uscatescu MV, Windyga J, Zülfikar B, Mantovani L. Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors. N Engl J Med. 2011 Nov
Kavakli K, Cogulu O, Karaca E, Durmaz B, Ozkinay F, Aydogdu S, Ozkilic H, Balkan C, Karapinar D, Ay Y. Micronucleus evaluation for determining the chromosomal breakages after radionuclide synovectomy in patients with hemophilia. Ann Nucl Med. 2012 Jan
Akin M, Balkan C, Karapinar DY, Kavakli K. The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms. Clin Appl Thromb Hemost. 2012 Jun
Olukman O, Sahin U, Kavakli T, Kavakli K. Investigation of acquired von Willebrand Syndrome in children with hypothyroidism: reversal after treatment with thyroxine. J Pediatr Endocrinol Metab. 2010 Sep
Akin M, Karapinar DY, Balkan C, Ay Y, Kavakli K. Resemblance to vWD types and laboratory diagnosis of obligatory carriers of type 3 von Willebrand disease. Clin Appl Thromb Hemost. 2011 Nov-Dec
Balkan C, Karapinar D, Aydogdu S, Ozcan C, Ay Y, Akin M, Kavakli K. Surgery in patients with haemophilia and high responding inhibitors: Izmir experience. Haemophilia. 2010 Nov
Yilmaz D, Akin M, Ay Y, Balkan C, Celik A, Ergün O, Kavakli K. A single centre experience in circumcision of haemophilia patients: Izmir protocol. Haemophilia. 2010 Nov
Akin M, Karapinar DY, Balkan C, Ay Y, Kavakli K. An evaluation of the DDAVP infusion test with PFA-100 and vWF activity assays to distinguish vWD types in children. Clin Appl Thromb Hemost. 2011 Oct
Kavakli K, Yesilipek A, Antmen B, Aksu S, Balkan C, Yilmaz D, Kupesiz A, Sasmaz I, Lindgren P, Mesterton J. The value of early treatment in patients with haemophilia and inhibitors. Haemophilia. 2010 May
Kavakli K, Cogulu O, Aydogdu S, Ozkiliç H, Durmaz B, Kirbiyik O, Ozkinay F, Balkan C, Karapinar D, Ay Y. Long-term evaluation of chromosomal breakages after radioisotope synovectomy for treatment of target joints in patients with haemophilia. Haemophilia. 2010 May
Peker E, Kavakli K, Balkan C, Karapinar D, Aydemir B. Incidence and clinical importance of lupus anticoagulant in children with recurrent upper respiratory tract infection. Clin Appl Thromb Hemost. 2011 Apr
Klintman J, Berntorp E, Astermark J; MIBS Study Group. Thrombin generation in vitro in the presence of bypassing agents in siblings with severe haemophilia A. Haemophilia. 2010 Jan
Fidanci ID, Kavakli K, Uçar C, Timur C, Meral A, Kilinç Y, Sayilan H, Kazanci E, Cağlayan SH. Factor 8 (F8) gene mutation profile of Turkish hemophilia A patients with inhibitors. Blood Coagul Fibrinolysis. 2008 Jul
Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Pediatr Hematol Oncol. 2008 Jun
Kavakli K, Aydogdu S, Taner M, Duman Y, Balkan C, Karapinar DY, Saydam G, Capaci K, Oktay A. Radioisotope synovectomy with rhenium186 in haemophilic synovitis for elbows, ankles and shoulders. Haemophilia. 2008 May
Hoots WK, Ebbesen LS, Konkle BA, Auerswald GK, Roberts HR, Weatherall J, Ferran JM, Ljung RC; Novoseven (F7HAEM-1505) Investigators. Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors. Haemophilia. 2008 May
Unuvar A, Kavakli K, Baytan B, Kazanci E, Sayli T, Oren H, Celkan T, Gursel T. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors. Haemophilia. 2008 Mar
Arslan MT, Ozyurek R, Kavakli K, Levent E, Ulger Z, Gurses D, Akyol B, Atay Y. Frequency of acquired von Willebrand's disease in children with congenital heart disease. Acta Cardiol. 2007 Aug
B. Balkan C, Kavakli K, Karapinar D. Spinal epidural haematoma in a patient with haemophilia Haemophilia. 2006 Jul
Astermark J, Oldenburg J, Carlson J, Pavlova A, Kavakli K, Berntorp E, Lefvert AK. Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia Blood. 2006 Dec
Kavakli K, Makris M, Zulfikar B, Erhardtsen E, Abrams ZS, Kenet G; NovoSeven trial (F7HAEM-1510) investigators. Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial. Thromb Haemost. 2006 Apr
Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. Blood Coagul Fibrinolysis. 2006 Apr
Kavakli K, Aydoğdu S, Omay SB, Duman Y, Taner M, Capaci K, Memiş A, Balkan C, Karapinar D. Long-term evaluation of radioisotope synovectomy with Yttrium 90 for chronic synovitis in Turkish haemophiliacs: Izmir experience. Haemophilia. 2006 Jan
Balkan C, Kavakli K, Karapinar D. Iliopsoas haemorrhage in patients with haemophilia: results from one centre. Haemophilia. 2005 Sep
Kavakli K, Avanoglu A, Celik A. Cost-effectivity of circumcision in hemophilia. J Pediatr Surg. 2005 Jul
Balkan C, Kavakli K, Kutukculer N, Aksu G, Yilmaz D, Aydinok Y. The effect of clotting factor concentrates on the immune system in HIV-negative haemophilics. Haemophilia. 2005 Jul
Onay UV, Kavakli K, Kilinç Y, Gürgey A, Aktuğlu G, Kemahli S, Ozbek U, Cağlayan SH. Molecular pathology of haemophilia B in Turkish patients: identification of a large deletion and 33 independent point mutations. Br J Haematol. 2003 Feb
Kavakli K, Canciani MT, Mannucci PM. Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children. Pediatr Hematol Oncol. 2002 Oct-Nov
Serdaroglu G, Tütüncüoglu S, Kavakli K, Tekgül H. Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid. J Child Neurol. 2002 Jan
Kavakli K, Hüseyinov A, Coker I, Aydinok Y, Nisli G. Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease. Haemophilia. 2001 Sep
Timur AA, Gürgey A, Aktuglu G, Kavakli K, Canatan D, Olek K, Caglayan SH. Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations. Haemophilia. 2001 Sep
Kavakli K, Nişli G. Circumcision, hemophilia, and being healthy in developing countries. Pediatr Hematol Oncol. 2001 Sep
Kavakli K, Aydinok Y, Karapinar D, Balkan C. DDAVP treatment in children with haemophilia B. Br J Haematol. 2001 Sep
Aydogdu S, Memis A, Kavakli K, Balkan C. The pelvifemoral incomplete bone bridge in a patient with mild haemophilia. Haemophilia. 2001 Mar
Aksit S, Vardar F, Kantar M, Kavakli K, Yucel G, Buyukinan M. Haemorrhagic shock and encephalopathy syndrome in four Turkish children. Acta Paediatr. 2000 May
Kavakli K, Kurugöl Z, Göksen D, Nisli G. Should hemophiliac patients be circumcised? Pediatr Hematol Oncol. 2000 Mar
Kavakli K. Fibrin glue and clinical impact on haemophilia care. Haemophilia. 1999 Nov
Aldedort LM, Miners A, Bohn R, Borrero P, Goudemand J, Hoots K, Kavakli K, Lee C, Roberts J, Schramm W, Szucs T, Wasserman J. Economic aspects of haemophilia care. Haemophilia. 1999 May
El-Maarri O, Kavakli K, Caglayan SH. Intron 22 inversions in the Turkish haemophilia A patients: prevalence and haplotype analysis. Haemophilia. 1999 May
Kavakli K, Nişli G, Kütükçüler N, Polat A, Aydinok Y, Oztop S, Cetingül N. Long-term prophylaxis and immune parameters in haemophilia. J Trop Pediatr. 1999 Apr
Kavakli K, Polat A, Hüseyinof A, Nisli G, Aydinok Y. Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease. Thromb Haemost. 1999 Apr
Avanoglu A, Celik A, Ulman I, Ozcan C, Kavakli K, Nişli G, Gökdemir A. Safer circumcision in patients with haemophilia: the use of fibrin glue for local haemostasis. BJU Int. 1999 Jan
Kavakli K, Aledort LM. Circumcision and haemophilia: a perspective. Haemophilia. 1998 Jan
Kavakli K, Gringeri A, Bader R, Nisli G, Polat A, Aydinok Y. Inhibitor development and substitution therapy in a developing country: Turkey. Haemophilia. 1998 Mar
Kavakli K, Nişli G, Polat A, Aydinok Y, Ozacar T. Hepatitis C virus and the treatment of hemophilia in Turkey. Transfusion. 1998 Aug
Kavakli K, Nişli G, Aydinok Y, Oztop S, Cetingül N, Aydoğdu S, Yalman O. Prophylactic therapy for hemophilia in a developing country, Turkey. Pediatr Hematol Oncol. 1997 Mar-Apr
Kavakli K, Nişli G, Cetingül N, Oztop S, Bilgiç A, Ozacar T. Hepatitis B vaccination in children with thalassemia, hemophilia and cancer. Pediatr Infect Dis J. 1996 Dec
Cetingül N, Kavakli K, Vergin C, Oztop S, Nişli G, Aydoğdu S, Ozacar T, Bilgiç A, Yüce G, Yağci R. alpha- Interferon-2b treatment for chronic hepatitis-B infection in children with cancer. J Trop Pediatr. 1996 Oct